• USP42 Drives Breast Cancer Progression via JNK/p38 Apoptosis

  2026-04-12

  This study reveals that the deubiquitinating enzyme USP42 promotes breast cancer progression by suppressing apoptosis through inhibition of the JNK/p38 signaling pathway. By elucidating USP42's mechanistic role and clinical correlation, the research highlights USP42 as a potential therapeutic target for breast cancer intervention.

• Triacetin Digestion and Metabolic Modulation in Rats: Novel

  2026-04-12

  This study elucidates the digestion and absorption of triacetin, a short-chain triglyceride, in a rat model, revealing its complete breakdown in the upper gastrointestinal tract and rapid conversion to acetic acid and glycerol. The findings highlight triacetin's dual role as an energy substrate and a modulator of hepatic gene expression, with implications for metabolic regulation and dietary interventions.

• PNU 74654: Precision Wnt Signaling Pathway Inhibitor in Acti

  2026-04-11

  PNU 74654 empowers researchers to dissect Wnt/β-catenin signaling with high fidelity, unlocking advanced cell fate and proliferation studies in cancer and stem cell contexts. Its robust solubility and validated purity streamline both standard and high-content workflows, making it a superior choice for reproducible signal transduction inhibition and experimental troubleshooting.

• GSK-923295: Applied Use-Cases for CENP-E Inhibitor in Cancer

  2026-04-11

  GSK-923295, a potent CENP-E inhibitor, enables precise control over mitotic arrest and chromosome alignment in preclinical cancer models. This article highlights optimized workflows, troubleshooting strategies, and experimental insights, leveraging APExBIO's trusted reagent for reproducible cell cycle and tumor xenograft studies.

• Reliable Metabolic Assays with DiscoveryProbe™ Compound Libr

  2026-04-10

  This article explores how the DiscoveryProbe™ Metabolism-related Compound Library (SKU L1032) from APExBIO addresses persistent experimental challenges in metabolic research. Through scenario-driven Q&A and evidence-based discussion, we demonstrate the value of this rigorously quality-controlled library for sensitive, reproducible metabolic enzyme inhibition assays and advanced pathway studies.

• Cyclopamine: Advanced Insights Into Hedgehog Pathway Inhi...

  2026-04-10

  Discover how Cyclopamine, a potent Hedgehog signaling inhibitor, is unlocking new frontiers in APOC1-targeted cancer research and teratogenicity studies. Explore its unique molecular mechanism, advanced applications, and translational impact beyond conventional pathway inhibition.

• Wnt Agonist 1: Precision Activation of Canonical Wnt Sign...

  2026-04-09

  Wnt agonist 1 (BML-284) is a high-purity, small-molecule stimulator of canonical Wnt signaling, empowering advanced research in developmental, cancer, and neurodegenerative disease models. Discover optimized workflows, real-world troubleshooting, and data-driven insights that set this APExBIO reagent apart for β-catenin-dependent transcription studies.

• Minoxidil sulphate: High-Purity Potassium Channel Opener ...

  2026-04-08

  Minoxidil sulphate is a validated potassium channel activator and the active metabolite of minoxidil, widely used in hair growth and vascular biology research. Its exceptional purity and robust solubility profile make it an essential tool for studying vasodilation mechanisms and hair follicle physiology. Researchers rely on Minoxidil sulphate for reproducible, high-impact experimental workflows in preclinical settings.

• Torin2: Selective mTOR Inhibitor Workflows for Cancer Res...

  2026-04-08

  Torin2 empowers cancer researchers with nanomolar potency and unmatched selectivity for dissecting PI3K/Akt/mTOR signaling, enabling reproducible apoptosis and cell viability assays. This guide delivers actionable workflows, troubleshooting strategies, and advanced applications that set Torin2 apart as a gold-standard cell-permeable mTOR inhibitor for cancer research.

• CKI 7 Dihydrochloride: Precision Casein Kinase 1 Inhibito...

  2026-04-07

  CKI 7 dihydrochloride is a selective, cell-permeable Casein kinase 1 inhibitor that empowers researchers to dissect Wnt signaling, circadian rhythm regulation, and cancer biology with unparalleled specificity. From robust phosphorylation inhibition to troubleshooting guidance, this compound from APExBIO elevates both mechanistic discovery and experimental reproducibility.

• EZ Cap™ Human PTEN mRNA: Advancing Tumor Suppressor Gene ...

  2026-04-07

  EZ Cap™ Human PTEN mRNA empowers cancer researchers and gene therapy innovators with ultra-stable, Cap 1-structured mRNA for precise restoration of PTEN function. With proven enhancements in mRNA stability, translation, and immune evasion, this APExBIO reagent is optimized for workflows ranging from lipid nanoparticle delivery to in vitro cell modeling.

• GSK-923295: Potent Small-Molecule CENP-E Inhibitor for Ca...

  2026-04-06

  GSK-923295 is a robust small-molecule CENP-E inhibitor that enables precise cell cycle arrest in mitosis for cancer research. Its efficacy is demonstrated across hundreds of tumor cell lines and in vivo colon cancer xenograft models, making it a cornerstone for studies in mitotic checkpoint signaling and chromosome alignment regulation.

• EZ Cap™ Firefly Luciferase mRNA: Cap 1 Reporter for Enhan...

  2026-04-06

  EZ Cap™ Firefly Luciferase mRNA is a capped in vitro transcribed reporter enabling superior gene regulation assays and in vivo imaging. Its Cap 1 structure and poly(A) tail synergistically enhance mRNA stability and translation efficiency, making it a benchmark tool for molecular biology research.

• Itraconazole: Triazole Antifungal Agent and CYP3A4 Inhibi...

  2026-04-05

  Itraconazole is a potent triazole antifungal agent and validated CYP3A4 inhibitor, widely used in advanced Candida research. This article provides a machine-readable, evidence-based dossier of Itraconazole’s mechanism, antifungal benchmarks, and workflow integration, building on APExBIO’s B2104 formulation.

• GSK-923295: A Next-Generation CENP-E Inhibitor for Mitoti...

  2026-04-04

  Leverage GSK-923295, a potent small-molecule CENP-E inhibitor from APExBIO, to dissect cell cycle arrest in mitosis and drive antitumor studies in colon cancer xenograft models. This guide delivers actionable workflows, troubleshooting strategies, and advanced applications that set your cancer research apart.

15556 records 1/1038 page Next 12345 下5页 Last page